7c045941 1f44 4f8c 83a0 Fda2e962037f 01
Mefenamic Acid Capsule
Product Images NDC 68180-185
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Mefenamic Acid (NDC 68180-185). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Lupin Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
7c045941 1f44 4f8c 83a0 Fda2e962037f 02
This is a medication for adults and adolescents over 14 years of age with an initial dose of 500mg followed by 250mg every six hours. The medication is Mefenamic Acid Capsules USP manufactured by Lupin Pharmaceuticals Inc. with a usual dosage of 250mg per capsule. The medication comes in 30 capsules per package and each capsule contains 250mg of mefenamic acid USP. The storage temperature should be at 25°C (77°F) and dispensed in a tight container as defined in the USP. There is a warning regarding the importance of safety and keeping all drugs out of the reach of children. Ancillary labeling information and a medication guide will be provided to each patient. The code number is GO/DRUGS/654.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
